Aging, drugs, and drug metabolism

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 2, 2012, Pages 137-139

  Le Couteur, David G ^a   McLachlan, Andrew J ^a   De Cabo, Rafael ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; BIOAVAILABILITY; DRUG EFFECT; EDITORIAL; HUMAN; PHARMACOKINETICS; PHYSIOLOGY;

AGING; BIOLOGICAL AVAILABILITY; HUMANS; PHARMACOKINETICS;

EID: 84856202631     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr084     Document Type: Article

References (16)

1. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56:163-184. (Pubitemid 38720828)
2. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21:217-230. (Pubitemid 46804936)
3. Le Couteur DG, Cogger VC, Markus AMA, et al. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology. 2001;33:537-543. (Pubitemid 32185214)
4. Le Couteur DG, McLean AJ. The aging liver-drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet. 1998;34:359-373. (Pubitemid 28192906)
5. Le Couteur DG, Muller M, Yang MC, Mellick GD, McLean AJ. Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev Environ Health. 2002;17:51-65.
6. Wood JG, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686-689. (Pubitemid 39061685)
7. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12:21-35.
8. Fontana L, Partridge L, Longo VD. Extending healthy life span-from yeast to humans. Science. 2010;328:321-326.
9. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460:392-395.
10. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342. (Pubitemid 44764104)
11. Le Couteur DG, McLachlan AJ, Quinn RJ, Simpson SJ, de Cabo R. Aging biology and novel targets for drug discovery. J Gerontol A Biol Sci Med Sci. 2011;67:168-174.
12. Lebel M, Picard F, Ferland G, Gaudreau P. Drugs, nutrients and phytoactive principles improving the health span of rodent models of human age-related diseases. J Gerontol A Biol Sci Med Sci. 2011. doi:10.1093/gerona/ glr038.
13. Smoliga JM, Vang O, Baur JA. Challenges of translating basic research into therapeutics: Resveratrol as an example. J Gerontol A Biol Sci Med Sci. 2011;67:158-167.
14. Lindley RJ. Drug trials in older people. J Gerontol A Biol Sci Med Sci. 2011;67:152-157.
15. McLachlan AJ, Pont LG. Drug metabolism in older people-a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci. 2011;67:175-180.
16. Hilmer SN, Gnjidic D, Abernethy DR. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults. J Gerontol A Biol Sci Med Sci. 2011;67:181-188.